OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

ADVANCED MIC.DEV. DL-,01/  US0079031078  /

München
5/6/2024  8:12:07 AM Chg. +2.02 Volume Bid5:13:48 PM Ask5:13:48 PM Market Capitalization Dividend Y. P/E Ratio
140.60EUR +1.46% 0
Turnover: 0.00		 144.24Bid Size: 4,500 144.32Ask Size: 4,500 234.27 bill.EUR - -
GlobeNewswire 2:15 PM Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease ...
GlobeNewswire 2:00 PM Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...
GlobeNewswire 1:30 PM Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
GlobeNewswire 1:00 PM EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Prol...
GlobeNewswire 5/3 Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024
GlobeNewswire 5/3 YieldMax™ ETFs Announces Monthly Distributions on CONY (109.51%), MSTY (103.22%), NFLY (67.74%), SQY...
GlobeNewswire 5/2 Outlook Therapeutics® to Present at the Retina World Congress 2024
GlobeNewswire 5/2 Kriya Announces Three Presentations at the 2024 Association for Research in Vision and Ophthalmology...
GlobeNewswire 5/2 YieldMax™ Launches Short TSLA Option Income Strategy ETF CRSH
GlobeNewswire 5/1 Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...
GlobeNewswire 5/1 Gene Therapies in Degenerative Retinal Disease Hold Potential to Capture Significant Portion of Mark...
TeleTrader 5/1 AI-related stocks plunge, Super Micro leads with 17% decline
GlobeNewswire 5/1 Micron First to Ship Critical Memory for AI Data Centers
GlobeNewswire 5/1 Alkeus Pharmaceuticals Announces Presentation of Positive Gildeuretinol Data in Early-Stage Stargard...
GlobeNewswire 5/1 4DMT Announces Presentations at ARVO 2024 Annual Meeting
GlobeNewswire 5/1 Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geog...
GlobeNewswire 5/1 Opthea Announces Upcoming Presentations at the Retina World Congress 2024
GlobeNewswire 5/1 Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024
GlobeNewswire 5/1 Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology ...
TeleTrader 4/30 AMD's revenue up 2% to $5.5B in Q1
GlobeNewswire 4/30 AMD Reports First Quarter 2024 Financial Results
GlobeNewswire 4/30 Lighthouse Guild Receives Grant from American Macular Degeneration Foundation (AMDF)
TeleTrader 4/30 Wall Street opens lower with Dow Jones falling 200 points
TeleTrader 4/26 Intel shares plunge 11% to 10-month low on gloomy outlook
GlobeNewswire 4/26 Belite Bio Announces $25 Million Registered Direct Offering